Sun Pharma Recalls Over 24K Prefilled Syringes Of Generic Medication In The Us Due To A Manufacturing Issue

Sun Pharma Recalls Over 24K Prefilled Syringes Of Generic Medication In The Us Due To A Manufacturing Issue

By, Admin 8 May 2023

Drug Major Sun Pharmaceutical Industries Is Recalling Pre-Filled Syringes Of A Drug, Used To Treat Infertility In Women, In The Us Market Due To A Manufacturing Issue, According To The Us Health Regulator.In Its Latest Enforcement Report, The Us Food And Drug Administration (Usfda) Noted That The Mumbai-Based Drug Major Is Recalling 24,194 Prefilled Syringes Of Fyremadel (Ganirelix Acetate) Injection. The Company Is Recalling The Affected Lot Due To The Presence Of Particulate Matter, The Usfda Said. The Product Was Manufactured By Sun Pharma And Distributed In The Us Market By New Jersey-Based Ferring Pharmaceuticals Inc. The Company Initiated The Countrywide (Us) Recall On April 19 This Year, Usfda Stated. The New Jersey-Based Sun Pharmaceutical Inc, A Unit Of The Company, Has Already Announced The Recall Of 16,450 Vials Of Norepinephrine Bitartrate Injection For "Failed Impurities/Degradation Specifications".As Per The Usfda, The Drugmaker Is Also Voluntarily Recalling Over 34,000 Bottles Of A Generic Medication, Used To Treat High Blood Pressure, In The Us Market Due To Failed Dissolution Testing.The Indian Pharmaceutical Industry Is The World'S Third-Largest By Volume And 14Th-Largest In Terms Of Value. India Exported Pharmaceuticals Worth Rs 1,75,040 Crore In The Financial Year 2021-22, Including Bulk Drugs/ Drug Intermediates.The Us Is The World'S Largest Market For Pharmaceutical Products.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!